Witnessing the stock’s movement on the chart, on Wednesday, Medtronic Plc (NYSE: MDT) had a quiet start as it plunged -0.47% to $97.87, before settling in for the price of $98.33 at the close. Taking a more long-term approach, MDT posted a 52-week range of $79.29-$99.37.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.39%. Meanwhile, its Annual Earning per share during the time was 0.39%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 2.48%. This publicly-traded company’s shares outstanding now amounts to $1.28 billion, simultaneously with a float of $1.28 billion. The organization now has a market capitalization sitting at $125.54 billion. At the time of writing, stock’s 50-day Moving Average stood at $93.30, while the 200-day Moving Average is $88.69.
Medtronic Plc (MDT) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Medtronic Plc’s current insider ownership accounts for 0.07%, in contrast to 86.32% institutional ownership. According to the most recent insider trade that took place on Sep 03 ’25, this organization’s EVP & President Cardiovascular sold 8,605 shares at the rate of 91.58, making the entire transaction reach 788,048 in total value, affecting insider ownership by 35,615.
Medtronic Plc (MDT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.35 per share during the current fiscal year.
Medtronic Plc’s EPS increase for this current 12-month fiscal period is 2.48% and is forecasted to reach 6.07 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 5.90% through the next 5 years, which can be compared against the 0.39% growth it accomplished over the previous five years trading on the market.
Medtronic Plc (NYSE: MDT) Trading Performance Indicators
Let’s observe the current performance indicators for Medtronic Plc (MDT). It’s Quick Ratio in the last reported quarter now stands at 1.50. Alongside those numbers, its PE Ratio stands at $27.02, and its Beta score is 0.79. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.67. Similarly, its price to free cash flow for trailing twelve months is now 23.67.
In the same vein, MDT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 3.62, a figure that is expected to reach 1.31 in the next quarter, and analysts are predicting that it will be 6.07 at the market close of one year from today.
Technical Analysis of Medtronic Plc (MDT)
Going through the that latest performance of [Medtronic Plc, MDT]. Its last 5-days volume of 7.26 million was inferior to the volume of 7.63 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 87.59% While, its Average True Range was 67.61.
Raw Stochastic average of Medtronic Plc (MDT) in the period of the previous 100 days is set at 92.28%, which indicates a major rise in contrast to 80.01% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.79 that was higher than 1.54 volatility it exhibited in the past 100-days period.
